AC Immune SA ACIU
- semorinemab — Alzheimer's Disease Phase 2
- PI-2620 — Alzheimer's Disease Phase 3
- PI-2620 — Progressive Supranuclear Palsy Phase 2
- ACI-35.030 — Alzheimer's Disease Phase 2
Tau (1 companies · 4 programs)
Companies with an active program directed at Tau.